- Home
- CVKD vs NTBL Comparison
CVKD vs NTBL Comparison
Compare CVKD & NTBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- NTBL
- Stock Information
- Founded
- CVKD 2022
- NTBL 2000
- Country
- CVKD United States
- NTBL United States
- Employees
- CVKD N/A
- NTBL N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- NTBL Biotechnology: Pharmaceutical Preparations
- Sector
- CVKD Health Care
- NTBL Health Care
- Exchange
- CVKD Nasdaq
- NTBL Nasdaq
- Market Cap
- CVKD 17.1M
- NTBL 4.6M
- IPO Year
- CVKD 2023
- NTBL N/A
- Fundamental
- Price
- CVKD $15.24
- NTBL $0.34
- Analyst Decision
- CVKD Strong Buy
- NTBL Buy
- Analyst Count
- CVKD 2
- NTBL 2
- Target Price
- CVKD $52.50
- NTBL $5.00
- AVG Volume (30 Days)
- CVKD 59.6K
- NTBL 8.0M
- Earning Date
- CVKD 11-08-2024
- NTBL 11-12-2024
- Dividend Yield
- CVKD N/A
- NTBL N/A
- EPS Growth
- CVKD N/A
- NTBL N/A
- EPS
- CVKD N/A
- NTBL N/A
- Revenue
- CVKD N/A
- NTBL $313,000.00
- Revenue This Year
- CVKD N/A
- NTBL N/A
- Revenue Next Year
- CVKD N/A
- NTBL N/A
- P/E Ratio
- CVKD N/A
- NTBL N/A
- Revenue Growth
- CVKD N/A
- NTBL 3812.50
- 52 Week Low
- CVKD $5.40
- NTBL $0.22
- 52 Week High
- CVKD $32.55
- NTBL $4.24
- Technical
- Relative Strength Index (RSI)
- CVKD 60.90
- NTBL 43.04
- Support Level
- CVKD $11.19
- NTBL $0.28
- Resistance Level
- CVKD $15.93
- NTBL $0.67
- Average True Range (ATR)
- CVKD 1.36
- NTBL 0.06
- MACD
- CVKD 0.23
- NTBL -0.00
- Stochastic Oscillator
- CVKD 61.01
- NTBL 27.53
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.
About NTBL Notable Labs Ltd.
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.